|
KU-55933 (CAS: 587871-26-9)
|
| SKU-Pack Size | Availability | Size | Price | |
| EBC51008-1ML | In Stock | 1mL(10mM in DMSO) | $103.50 | |
| EBC51008-5MG | In Stock | 5mg | $103.50 | |
| EBC51008-25MG | In Stock | 25mg | $268.50 | |
| EBC51008-50MG | In Stock | 50mg | $403.50 | |
| EBC51008-100MG | In Stock | 100mg | $523.50 |
| Please Select The Country You Are In To Find Your Local Distributor. |
| EbioCell | Phone:(540) 808-3925 | |
| Imperial Business Park 4819 Emperor Boulevard, | E-mail:order@ebiocell.com | |
| Canada | Suite 408 Durham, NC 27703, USA | Web:www.ebiocell.com |
| Product Information | |||||||||||||||||||||
| Synonym(s) | ATM Kinase Inhibitor | ||||||||||||||||||||
| Chemical Name | 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one | ||||||||||||||||||||
| Application | ATM Kinase Inhibitor is a cell-permeable, potent, selective and ATP-competitive ATM inhibitor | ||||||||||||||||||||
| CAS Number | 587871-26-9 | ||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||
| Molecular Weight | 395.49 | ||||||||||||||||||||
| Molecular Formula | C₂₁H₁₇NO₃S₂ | ||||||||||||||||||||
| SMILES | C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4 | ||||||||||||||||||||
| Target & IC50 | Atm: IC50 = 13 nM mTOR: IC50 = 9.3 μM PI3K: IC50 = 16.6 μM |
||||||||||||||||||||
| Solubility | DMSO: 39.6 mg/mL (100 mM) Ethanol: 19.8 mg/mL (50 mM) |
||||||||||||||||||||
| Preparing Stock Solutions |
|
||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||
| Storage | Store at -20° C | ||||||||||||||||||||
| Research Use | For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. | ||||||||||||||||||||
| Product Description | |
ATM Kinase Inhibitor (KU 55933) is a cell-permeable, potent, selective and ATP-competitive inhibitor of ATM (Ataxia telangiectasia mutated), a serine/threonine protein kinase, that exhibits an IC50 of 13 nmol/L and a Ki of 2.2 nmol/L. ATM is rapidly and specifically activated in response to DNA double-strand breaks in eukaryotic cells and signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NALP2 (NBS1), and BRCA1. |
| Specific Protocols | |